Country
Drug factories in Singapore
7 plants in Singapore are named on current U.S. prescription drug labels. FDA has inspected 6 of them; 0 had serious problems at their last inspection.
| Plant | City | Products | Last FDA inspection |
|---|---|---|---|
| Pfizer Asia Manufacturing Pte Ltd | Singapore | 66 | Problems found, fixed voluntarilyOct 2023 |
| Sanofi-Aventis Singapore Pte. Ltd. | Singapore | 32 | Problems found, fixed voluntarilyJun 2025 |
| Takeda Manufacturing Singapore Pte. Ltd. | Singapore | 14 | Not inspected on record |
| Roche Singapore Technical Operations Pte. Ltd. | Singapore | 11 | Problems found, fixed voluntarilyNov 2025 |
| Glaxo Wellcome Manufacturing Pte. Ltd | Jurong | 3 | Problems found, fixed voluntarilyOct 2023 |
| Lonza Biologics Tuas Pte. Ltd. | Singapore | 2 | Problems found, fixed voluntarilyJun 2023 |
| Sigma-Aldrich Pte Ltd | Singapore | 2 | No problems foundAug 2026 |